WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsDentsply Sirona Inc (XRAY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 673% more annual revenue ($28.43B vs $3.68B). MDLN leads profitability with a 4.1% profit margin vs -16.3%. XRAY earns a higher WallStSmart Score of 56/100 (C).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

XRAY

Buy

56

out of 100

Grade: C

Growth: 5.3Profit: 3.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.03

$24.89 discount

UndervaluedFair: $66.92Overvalued

Intrinsic value data unavailable for XRAY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

XRAY2 strengths · Avg: 8.0/10
PEG RatioValuation
0.778/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

XRAY3 concerns · Avg: 2.0/10
Operating MarginProfitability
1.8%3/10

Operating margin of 1.8%

Return on EquityProfitability
-36.4%2/10

ROE of -36.4% — below average capital efficiency

Profit MarginProfitability
-16.3%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : XRAY

The strongest argument for XRAY centers on PEG Ratio, Price/Book. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : XRAY

The primary concerns for XRAY are Operating Margin, Return on Equity, Profit Margin.

Key Dynamics to Monitor

MDLN profiles as a value stock while XRAY is a turnaround play — different risk/reward profiles.

MDLN is growing revenue faster at 14.8% — sustainability is the question.

XRAY generates stronger free cash flow (60M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

XRAY scores higher overall (56/100 vs 52/100). MDLN offers better value entry with a 32.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Dentsply Sirona Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.

Want to dig deeper into these stocks?